The current results prompt us to hypothesize that the increase in the levels of expression of TGF-β during tumor progression stimulates the downregulation of TβRs, both in the tumor itself and in stroma (CAFs), which results in the TβR-mediated reduction of apoptosis. This evidence concerns the gene DNMT3A and neoplasm.